These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3587912)

  • 21. Matrix metalloproteinases: a role in the contraction of vitreo-retinal scar tissue.
    Sheridan CM; Occleston NL; Hiscott P; Kon CH; Khaw PT; Grierson I
    Am J Pathol; 2001 Oct; 159(4):1555-66. PubMed ID: 11583981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective Effects of Fucoidan on Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells and Progression of Proliferative Vitreoretinopathy.
    Zhang Y; Zhao D; Yang S; Yao H; Li M; Zhao C; Zhang J; Xu GT; Li H; Wang F
    Cell Physiol Biochem; 2018; 46(4):1704-1715. PubMed ID: 29698960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor.
    Ando A; Ueda M; Uyama M; Masu Y; Ito S
    Br J Ophthalmol; 2000 Nov; 84(11):1306-11. PubMed ID: 11049960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of platelet-derived growth factor by interleukin-1 beta and transforming growth factor-beta-stimulated retinal pigment epithelial cells leads to contraction of collagen gels.
    Choudhury P; Chen W; Hunt RC
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):824-33. PubMed ID: 9112977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreous fibronectin and platelet-derived growth factor. New model for traction retinal detachment.
    Yeo JH; Sadeghi J; Campochiaro PA; Green WR; Glaser BM
    Arch Ophthalmol; 1986 Mar; 104(3):417-21. PubMed ID: 3954643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human retinal pigment epithelial cell cultures: phenotypic modulation by vitreous and macrophages.
    Kirchhof B; Kirchhof E; Ryan SJ; Sorgente N
    Exp Eye Res; 1988 Sep; 47(3):457-63. PubMed ID: 3181329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of rho-kinase pathway in contractile activity of rabbit RPE cells in vivo and in vitro.
    Zheng Y; Bando H; Ikuno Y; Oshima Y; Sawa M; Ohji M; Tano Y
    Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):668-74. PubMed ID: 14744913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of retinal pigment epithelial cell attachment by a synthetic peptide derived from the cell-binding domain of fibronectin.
    Avery RL; Glaser BM
    Arch Ophthalmol; 1986 Aug; 104(8):1220-2. PubMed ID: 3741254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of thrombin in proliferative vitreoretinopathy.
    Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy.
    Stern WH; Lewis GP; Erickson PA; Guerin CJ; Anderson DH; Fisher SK; O'Donnell JJ
    Am J Ophthalmol; 1983 Jul; 96(1):33-42. PubMed ID: 6869478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR.
    Behar-Cohen FF; Thillaye-Goldenberg B; de Bizemont T; Savoldelli M; Chauvaud D; de Kozak Y
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3915-24. PubMed ID: 11053294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Periostin in the Pathogenesis of Proliferative Vitreoretinopathy].
    Ishikawa K
    Nippon Ganka Gakkai Zasshi; 2015 Nov; 119(11):772-80. PubMed ID: 26685481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells.
    Campochiaro PA; Glaser BM
    Arch Ophthalmol; 1985 Apr; 103(4):576-9. PubMed ID: 3985844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multimodal Approaches for the Analysis of Retinal Functional Disorders―Focusing on Retinal Detachment].
    Terasaki H
    Nippon Ganka Gakkai Zasshi; 2017 Mar; 121(3):185-231. PubMed ID: 30088405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of platelet-derived growth factor on the formation of proliferative vitreoretinopathy].
    Liang Y; Li X; Fan J; Zhao M; Jiang Y
    Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):144-7. PubMed ID: 11955317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy.
    Lei H; Hovland P; Velez G; Haran A; Gilbertson D; Hirose T; Kazlauskas A
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2335-42. PubMed ID: 17460299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of breakdown of the blood-retinal barrier in cell-injection models of proliferative vitreoretinopathy.
    Sen HA; Robertson TJ; Conway BP; Campochiaro PA
    Arch Ophthalmol; 1988 Sep; 106(9):1291-4. PubMed ID: 3415556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transferrin receptor expression by retinal pigment epithelial cells in proliferative vitreoretinopathy.
    Baudouin C; Brignole F; Fredj-Reygrobellet D; Nègre F; Bayle J; Gastaud P
    Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2822-9. PubMed ID: 1382045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix and the retinal pigment epithelium in proliferative retinal disease.
    Hiscott P; Sheridan C; Magee RM; Grierson I
    Prog Retin Eye Res; 1999 Mar; 18(2):167-90. PubMed ID: 9932282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.